title: What Is the Malignancy Risk in Neurofibromatosis Type 1?
authors.affiliation: St Mary's Hospital, Central Manchester Hospitals Foundation Trust, Manchester, United Kingdom gareth.evans@cmft.nhs.uk.
authors.forename: D Gareth R
authors.initials: DG
authors.lastname: Evans
mesh_terms: D006801:Humans; D009456:Neurofibromatosis 1; D012306:Risk